chr19-39870296-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003890.3(FCGBP):c.11908G>A(p.Asp3970Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000738 in 1,367,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000037 ( 0 hom. )
Consequence
FCGBP
NM_003890.3 missense
NM_003890.3 missense
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.783
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGBP | NM_003890.3 | c.11908G>A | p.Asp3970Asn | missense_variant | 33/36 | NP_003881.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGBP | ENST00000616721.6 | c.11869G>A | p.Asp3957Asn | missense_variant | 25/28 | 1 | ENSP00000481056.3 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152200Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
56
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251238Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135856
GnomAD3 exomes
AF:
AC:
22
AN:
251238
Hom.:
AF XY:
AC XY:
9
AN XY:
135856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000370 AC: 45AN: 1215460Hom.: 0 Cov.: 32 AF XY: 0.0000349 AC XY: 21AN XY: 602392
GnomAD4 exome
AF:
AC:
45
AN:
1215460
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
602392
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000368 AC: 56AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74474
GnomAD4 genome
AF:
AC:
56
AN:
152318
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.15472G>A (p.D5158N) alteration is located in exon 33 (coding exon 33) of the FCGBP gene. This alteration results from a G to A substitution at nucleotide position 15472, causing the aspartic acid (D) at amino acid position 5158 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at